Betterlife Pharma Inc (BETR.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
| 04-2024 | 01-2024 | 10-2023 | 07-2023 | 04-2023 | |
| Operating Expenses | 2,267 | 730 | 699 | 1,015 | 766 |
| Operating Income | -2,267 | -730 | -699 | -1,015 | -766 |
| Interest Expense | 63 | 36 | 7 | 6 | 2 |
| Other Income | 281 | 73 | 492 | -7 | -196 |
| Pre-tax Income | -2,049 | -693 | -214 | -1,028 | -964 |
| Net Income Continuous | -2,049 | -693 | -214 | -1,028 | -964 |
| Minority Interests | 103 | -609 | 18 | 8 | N/A |
| Net Income | $-1,947 | $-1,303 | $-195 | $-1,019 | $-964 |
| EPS Basic Total Ops | -0.02 | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.02 | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | 0.00 | -0.01 | -0.01 |
| EBITDA(a) | $-1,986 | $-657 | $-207 | $-1,022 | $-962 |